
Seamless entry for advanced healthcare technologies. We manage Medical Device Customs Clearance, validating technical NMPA dossiers and safety certifications to guarantee rapid entry for medical assets.
Accelerated global aging is driving a surge in wheelchair import demand,and medical device customs clearance at Ningbo Port faces multiple challenges such as customs valuation and commodity inspection. Based on the latest trade rules for 2026,this article deeply analyzes the three core risk points in wheelchair imports: tariff losses caused by HS code classification deviations,return crises due to invalid medical device registration certificates,and blind spots in connecting EU CE certification with domestic standards. Zhongshitong foreign trade experts reveal key points for pre-audit scheme design through real cases,emphasizing the specific application path of RCEP certificate of origin tariff reduction policies at Ningbo Port,providing import enterprises with an actionable compliance operation framework.
In 2026,domestic demand for high-end medical device imports continues to rise. Most small and medium-sized distributors are unfamiliar with the latest rules regarding NMPA filing,UDI compliance,and port customs clearance,making them highly prone to clearance delays,returns,or even administrative penalties. A professional import medical device agent can complete document pre-audit and qualification processing in advance,avoid multi-dimensional risks such as tariffs,compliance,and logistics,and significantly shorten the customs clearance cycle.